share_log
Reuters ·  Apr 4 11:49
Neuphoria Therapeutics Inc : Maxim Group Cuts Target Price to $18 From $48
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 327

Recommended

Write a comment